Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2023-N-0008]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

The Food and Drug Administration (FDA or Agency) is requesting nominations for a voting consumer representative to serve on the Genetic Metabolic Diseases Advisory Committee. FDA is also requesting that any consumer organizations interested in participating in the selection of a voting consumer representative to serve on the Genetic Metabolic Diseases Advisory Committee notify FDA in writing. Nominees recommended to serve as a voting consumer representative may either be self-nominated or may be nominated by a consumer organization. Nominations will be accepted for the current vacancy effective with this notice. FDA seeks to include the views of members of all gender groups, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups.

# DATES:

                        Any consumer organization interested in participating in the selection of an appropriate voting member to represent consumer interests on the Genetic Metabolic Diseases Advisory Committee may send a letter or email stating that interest to FDA (see                         **ADDRESSES**                        ) by February 12, 2024 for vacancy listed in this notice. Concurrently, nomination materials for prospective candidates should be sent to FDA (see                         **ADDRESSES**                        ) by February 12, 2024. Nominations will be accepted for current vacancy.                    

# ADDRESSES:

                        All statements of interest from consumer organizations interested in participating in the selection process should be submitted electronically to                         *ACOMSSubmissions@fda.hhs.gov*                         or by mail to Advisory Committee and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5122, Silver Spring, MD 20993-0002.                    

                        Consumer representative nominations should be submitted electronically by logging into the FDA Advisory Committee Membership Nomination                               ( print page 86343)                            Portal:                         *https://www.accessdata.fda.gov/​scripts/​FACTRSPortal/​FACTRS/​index.cfm*                         or by mail to Advisory Committee Oversight and Management Staff, 10903 New Hampshire Ave., Bldg. 32, Rm. 5122, Silver Spring, MD 20993-0002. Additional information about becoming a member of an FDA advisory committee can also be obtained by visiting FDA's website at                         *https://www.fda.gov/​AdvisoryCommittees/​default.htm*.                    

# FOR FURTHER INFORMATION CONTACT:

 

*For questions relating to participation in the selection process:*                         Kimberly Hamilton, Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5122, Silver Spring, MD 20993-0002, 301-796-8220,                         *kimberly.hamilton@fda.hhs.gov*.                    

*For questions relating to the Genetic Metabolic Diseases Advisory Committee:*                         Moon Choi, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-796-2894,                         *GEMDAC@fda.hhs.gov*.                    

# SUPPLEMENTARY INFORMATION:

                    FDA is requesting nominations for a voting consumer representative on the Genetic Metabolic Diseases Advisory Committee. Elsewhere in this                     **Federal Register**                    , FDA is publishing separate documents regarding:                

1. Genetic Metabolic Diseases Advisory Committee; Notice of Establishment

2. Request for Nominations for Voting Members on a Public Advisory Committee: Genetic Metabolic Diseases Advisory Committee

3. Request for Nominations of Individuals and Industry Organizations for the Genetic Metabolic Diseases Advisory Committee

## I. Function and General Description of the Committee Duties

### Genetic Metabolic Diseases Advisory Committee

The Committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug and biologic products for use in the treatment of genetic metabolic diseases and makes appropriate recommendations to the Commissioner of Food and Drugs.

## II. Criteria for Members

Persons nominated for membership as a consumer representative on this committee should meet the following criteria: (1) demonstrate an affiliation with and/or active participation in consumer or community-based organizations, (2) be able to analyze technical data, (3) understand research design, (4) discuss benefits and risks, and (5) evaluate the safety and efficacy of products under review. The consumer representative should be able to represent the consumer perspective on issues and actions before the advisory committee; serve as a liaison between the committee and interested consumers, associations, coalitions, and consumer organizations; and facilitate dialogue with the advisory committees on scientific issues that affect consumers.

## III. Selection Procedures

                    Selection of members representing consumer interests is conducted through procedures that include the use of organizations representing the public interest and public advocacy groups. These organizations recommend nominees for the Agency's selection. Representatives from the consumer health branches of Federal, State, and local governments also may participate in the selection process. Any consumer organization interested in participating in the selection of an appropriate voting member to represent consumer interests should send a letter stating that interest to FDA (see                     **ADDRESSES**                    ) within 30 days of publication of this document.                

Within the subsequent 60 days, FDA will compile a list of consumer organizations that will participate in the selection process and will forward to each such organization a ballot listing at least two qualified nominees selected by the Agency based on the nominations received, together with each nominee's current curriculum vitae or résumé. Ballots are to be filled out and returned to FDA within 30 days. The nominee receiving the highest number of votes ordinarily will be selected to serve as the member representing consumer interests for that particular advisory committee.

## IV. Nomination Procedures

                    Any interested person or organization may nominate one or more qualified persons to represent consumer interests on the Genetic Metabolic Diseases Advisory Committee with the exception of the following: Individuals who are not U.S. citizens or nationals cannot be appointed as advisory committee members (42 U.S.C. 217(a)) in FDA. Self-nominations are also accepted. Nominations must include a current, complete résumé or curriculum vitae for each nominee, including current business and/or home address, telephone number, and email address if available; a signed copy of the Acknowledgment and Consent form available at the FDA Advisory Nomination Portal (see                     **ADDRESSES**                    ); and a list of consumer or community-based organizations for which the candidate can demonstrate active participation.                

Nominations should also specify the advisory committee for which the nominee is recommended. In addition, nominations must also acknowledge that the nominee is aware of the nomination, unless self-nominated. FDA will ask potential candidates to provide detailed information concerning such matters related to financial holdings, employment, and research grants and/or contracts to permit evaluation of possible sources of conflicts of interest. Members will be invited to serve for terms up to 4 years.

FDA will review all nominations received within the specified timeframes and prepare a ballot containing the names of qualified nominees. Names not selected will remain on a list of eligible nominees and be reviewed periodically by FDA to determine continued interest. After selecting qualified nominees for the ballot, FDA will provide those consumer organizations that are participating in the selection process with the opportunity to vote on the listed nominees. Only organizations vote in the selection process. Persons who nominate themselves to serve as voting consumer representatives will not participate in the selection process.

                    This notice is issued under the Federal Advisory Committee Act (5 U.S.C. 1001*et seq.*) and 21 CFR part 14, relating to advisory committees.                

Dated: December 7, 2023.

Lauren K. Roth,

Associate Commissioner for Policy.

[FR Doc. 2023-27302 Filed 12-12-23; 8:45 am]

BILLING CODE 4164-01-P